We show that targeting APOBEC3G affected TGFβ-induced smad2 activation bridging APOBEC3G and the TGFβ pathway and illustrate the functions and mechanisms of APOBEC3G in GBM. This evidence concerns the gene SMAD2 and glioblastoma.